VEA
IMCR icon

Virtus ETF Advisers’s Immunocore IMCR Stock Holding History

Virtus ETF Advisers’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,536
Closed -$340K – 595
2024
Q4 		$340K Buy
11,536
+3,238
+39% +$102K 0.14% 216
2024
Q3 		$258K Hold
8,298
– – 0.12% 239
2024
Q2 		$281K Buy
8,298
+2,336
+39% +$119K 0.14% 235
2024
Q1 		$388K Buy
5,962
+858
+17% +$58.9K 0.21% 198
2023
Q4 		$349K Sell
5,104
-161
-3% -$8.37K 0.22% 188
2023
Q3 		$273K Sell
5,265
-684
-11% -$40.5K 0.17% 211
2023
Q2 		$357K Buy
5,949
+722
+14% +$41.2K 0.21% 149
2023
Q1 		$258K Buy
5,227
+96
+2% +$5.4K 0.14% 276
2022
Q4 		$293K Sell
5,131
-3,507
-41% -$197K 0.15% 278
2022
Q3 		$405K Buy
8,638
+125
+1% +$5.96K 0.16% 228
2022
Q2 		$318K Buy
8,513
+3,297
+63% +$107K 0.12% 262
2022
Q1 		$156K Sell
5,216
-307
-6% -$7.75K 0.07% 222
2021
Q4 		$189K Buy
5,523
+164
+3% +$5.94K 0.07% 231
2021
Q3 		$199K Sell
5,359
-275
-5% -$9.28K 0.09% 271
2021
Q2 		$220K Buy
+5,634
New +$217K 0.09% 274

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Virtus ETF Advisers's IMCR Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Immunocore (IMCR) in Q1 2025, closing a stake of 11,536 shares — an estimated $340K sold.

Virtus ETF Advisers first reported a position in IMCR in Q2 2021 and held it in 15 quarters. The position peaked at $405K in Q3 2022. 116 funds tracked by Wall St. Rank hold IMCR as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Immunocore position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 11,536 Immunocore shares in Q1 2025, an estimated $340K.
  • Virtus ETF Advisers first reported a position in Immunocore in Q2 2021 and held it in 15 quarters.
  • Virtus ETF Advisers's Immunocore position peaked at $405K in Q3 2022.
  • 116 funds tracked by Wall St. Rank held Immunocore as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.